Congenital adrenal hyperplasia (CAH) is a rare genetic disorder affecting the adrenal glands. People with CAH produce lower levels of cortisol, also known as “the stress hormone,” which has an effect on energy, blood pressure, and the body’s response to stress, illness and injury. While steroid medications can effectively replace the body’s cortisol, they can be difficult to balance and often produce unwanted side effects.
Right now, doctors at select centers in the U.S. are accepting participants for a new clinical research study. The study is for an investigational oral drug for CAH, designed to correct hormone imbalance and potentially reduce the necessary dose of traditional steroid medications. If you are 18 years of age or older, and have been diagnosed with classic CAH, you may qualify to participate. If you join, you will receive study-related care and medication at no cost, and will also be compensated for your time and travel.
If you qualify and choose to join the study, you will receive study-related:
* You do not need insurance to participate.
See If You Qualify
To see if you might qualify for the study, and to get connected with the study center in your area to learn more, please take the questionnaire below.